Home › NDC Lookup › RxCUI directory › RxCUI 2682691

0.4 ML nogapendekin alfa inbakicept-pmln 1 MG/ML Intravesical Solution [Anktiva] — RxCUI 2682691

RxNorm drug concept · Semantic branded drug
RxCUI 2682691 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2682691
Official name0.4 ML nogapendekin alfa inbakicept-pmln 1 MG/ML Intravesical Solution [Anktiva]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known as0.4 ML Anktiva 1 MG/ML Intravesical Solution; Anktiva 400 MCG in 0.4 ML Intravesical Solution; Anktiva 400 MCG per 0.4 ML Intravesical Solution
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How 0.4 ML nogapendekin alfa inbakicept-pmln 1 MG/ML... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 0.4 ML nogapendekin alfa inbakicept-pmln 1 MG/ML Intravesical Solution [Anktiva] RxCUI 2682691

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Nogapendekin alfa inbakicept 2682678
    • Nogapendekin alfa inbakicept-pmln 2682677
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Anktiva 2682686
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Nogapendekin alfa inbakicept Intravesical Solution 2719370
    • Nogapendekin alfa inbakicept-pmln Intravesical Solution 2719372
    • Nogapendekin alfa inbakicept Intravesical Product 2719369
    • Nogapendekin alfa inbakicept-pmln Intravesical Product 2719371
    • Nogapendekin alfa inbakicept Intravesical Solution [Anktiva] 2719376
    • Nogapendekin alfa inbakicept-pmln Intravesical Solution [Anktiva] 2719377
    • Anktiva Intravesical Product 2719375
    • Intravesical Solution 2719932
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • 0.4 ML nogapendekin alfa inbakicept-pmln 1 MG/ML Intravesical Solution SCD · 2682684
  • Nogapendekin alfa inbakicept-pmln 1 MG/ML SCDC · 2682679
  • Nogapendekin alfa inbakicept Intravesical Solution SCDF · 2719370
  • Nogapendekin alfa inbakicept-pmln Intravesical Solution SCDFP · 2719372
  • Nogapendekin alfa inbakicept Intravesical Product SCDG · 2719369
  • Nogapendekin alfa inbakicept-pmln Intravesical Product SCDGP · 2719371

Brand-Name Concepts

  • Nogapendekin alfa inbakicept-pmln 1 MG/ML [Anktiva] SBDC · 2682687
  • Nogapendekin alfa inbakicept Intravesical Solution [Anktiva] SBDF · 2719376
  • Nogapendekin alfa inbakicept-pmln Intravesical Solution [Anktiva] SBDFP · 2719377
  • Anktiva Intravesical Product SBDG · 2719375
  • Anktiva BN · 2682686

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 2682691 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
81481-0803-01 1 VIAL, GLASS in 1 BOX (81481-803-01) / .4 mL in 1 VIAL, GL... ANKTIVA Altor BioScience, LLC, an indirect wholly-owned subsidiary of ImmunityBio, Inc. 2024-05-06
Observed labelers: Altor BioScience, LLC, an indirect wholly-owned subsidiary of ImmunityBio, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J9028 Inj, nogapendekin pmln, 1mcg 1 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.